Table 4. Comparison of pre- and post-treatment variables in the CHC patients with SVR stratified by baseline IR.

	SVR (G1 and G2) with baseline IR(n = 63)		Paired t-testP values	SVR (G1 and G2) without baseline IR(n = 132)		Paired t-testP values
	Pre- treatmentvalue	Post-treatmentvalue		Pre- treatmentvalue	Post-treatmentvalue
Male (%)	37 (62.7%)			68 (60.1%)
Age (yr)	54.5+/−12.6			52.3+/−12.5
BMI	25.7+/−3.6	25.5+/−3.5	0.111	23.5+/−3.0	23.3+/−2.9	0.201
IL-28B rs12979860CC/CT+TT, n(CC%)	59/4(93.6%)			121/7(91.66%)
TG(mg/dL)	106.1+/−45.0	130.6+/−85.1	0.004*	96.0+/−44.7	113.1+/−65.5	0.003*
TC(mg/dL)	166. 0+/−29.7	182.4+/−40.9	<0.001*	168.3+/−32.8	184.1+/−36.1	<0.001*
HDL(mg/dL)	43.8+/−13.2	47.0+/−11.6	0.019*	51.2+/−13.6	52.4+/−14.7	0.188
LDL(mg/dL)	100.5+/−25.5	112.3+/−35.9	0.002*	100.3+/−28.6	112.9+/−31.4	<0.001*
TG/HDL	2.7+/−1.8	3.2+/−3.0	0.135	2.0+/−1.2	2.4+/−2.2	0.022*
Apo AI(g/L)	1.28+/−0.26	1.37+/−0.23	0.012*	1.45+/−0.26	1.48+/−0.26	0.111
Apo B (g/L)	0.84+/−0.17	0.87+/−0.20	0.274	0.80+/−0.19	0.88+/−0.23	<0.001*
Sugar (mg/dL)	116.3+/−44.6	120.1+/−76.5	0.601	90.2+/−8.9	95.0+/−15.7	0.001*
Insulin (µIU/mL)	19.7+/−21.9	16.8+/−27.0	0.223	6.9+/−2.8	8.0+/−4.6	0.016*
C-peptide (ng/mL)	3.9+/−2.5	3.0+/−1.5	0.019*	1.9+/−1.0	2.2+/−1.8	0.095
Hb-A1c (%; mmol/mol)	6.2+/−1.3;44+/−14	5.9+/−0.8;41+/−9	0.047*	5.6+/−0.4;37.5+/−4.5	5.6+/−0.5;37.5+/−5.5	0.546
HOMA-IR	6.2+/−11.7	4.6+/−6.7	0.04*	1.5+/−0.5	1.9+/−1.2	0.002*

*p<0.05.